The Efficacy of Phytoestrogens and Selective Estrogen Receptor Modulators in Perimenopause-Related Depression
Latest Information Update: 17 May 2021
At a glance
- Drugs P 081 (Primary) ; Raloxifene (Primary) ; Estradiol
- Indications Depressive disorders
- Focus Therapeutic Use
- 05 Jun 2015 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
- 09 May 2012 Planned end date changed from 1 Feb 2012 to 1 Feb 2014 as reported by ClinicalTrials.gov.
- 14 Jul 2009 Planned end date added to 1 Feb 2012 as reported by ClinicalTrials.gov.